Anti-TNF

Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study
Anna Moltó, Adrien Etcheto, Laure Gossec, Nadia Boudersa, Pascal Claudepierre, Nicolas Roux, Lucie Lemeunier, Antoine Martin, Lartitia Sparsa, Pascal Coquerelle, Martin Soubrier, Serge Perrot, Maxime Dougados

Annals of the Rheumatic Diseases Apr 2018, 77 (4) 533-540; DOI: 10.1136/annrheumdis-2017-212378
Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study
Peter C Taylor, Michael H Schiff, Qingmin Wang, Yusang Jiang, Yanli Zhuang, Regina Kurrasch, Shruti Daga, Ravi Rao, Paul P Tak, Benjamin Hsu

Annals of the Rheumatic Diseases May 2018, 77 (5) 658-666; DOI: 10.1136/annrheumdis-2017-212496
Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers
René Lindholm Cordtz, Samuel Hawley, Daniel Prieto-Alhambra, Pil Højgaard, Kristian Zobbe, Søren Overgaard, Anders Odgaard, Lars Erik Kristensen, Lene Dreyer

Annals of the Rheumatic Diseases May 2018, 77 (5) 684-689; DOI: 10.1136/annrheumdis-2017-212424
Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial
Désirée van der Heijde, Xenofon Baraliakos, Kay-Geert A Hermann, Robert B M Landewé, Pedro M Machado, Walter P Maksymowych, Owen R Davies, Natasha de Peyrecave, Bengt Hoepken, Lars Bauer, Tommi Nurminen, Juergen Braun

Annals of the Rheumatic Diseases May 2018, 77 (5) 699-705; DOI: 10.1136/annrheumdis-2017-212377
Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4
Paul Emery, Jiří Vencovský, Anna Sylwestrzak, Piotr Leszczyński, Wieslawa Porawska, Barbara Stasiuk, Joanna Hilt, Zdenka Mosterova, Soo Yeon Cheong, Jeehoon Ghil

Annals of the Rheumatic Diseases Dec 2017, 76 (12) 1986-1991; DOI: 10.1136/annrheumdis-2017-211591
Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis
Wen-Xiu Mo, Shan-Shan Yin, Hua Chen, Chen Zhou, Jia-Xin Zhou, Li-Dan Zhao, Yun-Yun Fei, Hua-Xia Yang, Jing-Bo Guo, Yu-Jia Mao, Lin-Fang Huang, Wen-Jie Zheng, Wen Zhang, Jian-Min Zhang, Wei He, Xuan Zhang

Annals of the Rheumatic Diseases Dec 2017, 76 (12) 2075-2084; DOI: 10.1136/annrheumdis-2016-211069
Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register
Elisabeth Lie, Ulf Lindström, Tatiana Zverkova-Sandström, Inge C Olsen, Helena Forsblad-d'Elia, Johan Askling, Meliha C Kapetanovic, Lars Erik Kristensen, Lennart T H Jacobsson

Annals of the Rheumatic Diseases Sep 2017, 76 (9) 1515-1521; DOI: 10.1136/annrheumdis-2016-210931
Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis
Audrey S L Low, Deborah P M Symmons, Mark Lunt, Louise K Mercer, Chris P Gale, Kath D Watson, William G Dixon, Kimme L Hyrich

Annals of the Rheumatic Diseases Apr 2017, 76 (4) 654-660; DOI: 10.1136/annrheumdis-2016-209784
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
Christina Charles-Schoeman, Gerd Burmester, Peter Nash, Cristiano A F Zerbini, Koshika Soma, Kenneth Kwok, Thijs Hendrikx, Eustratios Bananis, Roy Fleischmann

Annals of the Rheumatic Diseases Jul 2016, 75 (7) 1293-1301; DOI: 10.1136/annrheumdis-2014-207178
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Louise K Mercer, James B Galloway, Mark Lunt, Rebecca Davies, Audrey L S Low, William G Dixon, Kath D Watson, BSRBR Control Centre Consortium, Deborah P M Symmons, Kimme L Hyrich

Annals of the Rheumatic Diseases Mar 2017, 76 (3) 497-503; DOI: 10.1136/annrheumdis-2016-209389

Main menu

Anti-TNF

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Anti-TNF

Pages